Peptidomimetic inhibitors targeting the CCR5-binding site on the human immunodeficiency virus type-1 gp120 glycoprotein complexed to CD4. 2010

Markus Seitz, and Peter Rusert, and Kerstin Moehle, and Alexandra Trkola, and John A Robinson
Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich X, Switzerland.

A helical tyrosine-sulfated epitope in CCR5 that is recognized by the human immunodeficiency virus type-1 envelope glycoprotein gp120 in its CD4-induced conformation can be mimicked structurally by a cyclic β-hairpin peptide containing two sulfated tyrosine residues at positions i and i + 2 along one β-strand.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D015699 HIV Envelope Protein gp120 External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV. Envelope Glycoprotein gp120, HIV,HTLV-III gp120,env Protein gp120, HIV,gp120(HIV),HIV Envelope Glycoprotein gp120,gp120 Envelope Glycoprotein, HIV,HTLV III gp120,gp120, HTLV-III
D015704 CD4 Antigens 55-kDa antigens found on HELPER-INDUCER T-LYMPHOCYTES and on a variety of other immune cell types. They are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MAJOR HISTOCOMPATIBILITY COMPLEX class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. T4 antigens also serve as INTERLEUKIN-15 receptors and bind to the HIV receptors, binding directly to the HIV ENVELOPE PROTEIN GP120. Antigens, CD4,CD4 Molecule,CD4 Receptor,CD4 Receptors,Receptors, CD4,T4 Antigens, T-Cell,CD4 Antigen,Receptors, Surface CD4,Surface CD4 Receptor,Antigen, CD4,Antigens, T-Cell T4,CD4 Receptor, Surface,CD4 Receptors, Surface,Receptor, CD4,Surface CD4 Receptors,T-Cell T4 Antigens,T4 Antigens, T Cell
D017433 Protein Structure, Secondary The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to ALPHA-HELICES; BETA-STRANDS (which align to form BETA-SHEETS), or other types of coils. This is the first folding level of protein conformation. Secondary Protein Structure,Protein Structures, Secondary,Secondary Protein Structures,Structure, Secondary Protein,Structures, Secondary Protein
D057786 Peptidomimetics Compounds that are designed to mimic the 3D structure of a natural peptide or protein. Peptidomimetic

Related Publications

Markus Seitz, and Peter Rusert, and Kerstin Moehle, and Alexandra Trkola, and John A Robinson
January 2003, Journal of virology,
Markus Seitz, and Peter Rusert, and Kerstin Moehle, and Alexandra Trkola, and John A Robinson
January 1992, The Journal of experimental medicine,
Markus Seitz, and Peter Rusert, and Kerstin Moehle, and Alexandra Trkola, and John A Robinson
April 1993, The Journal of experimental medicine,
Markus Seitz, and Peter Rusert, and Kerstin Moehle, and Alexandra Trkola, and John A Robinson
September 1994, Biochemistry,
Markus Seitz, and Peter Rusert, and Kerstin Moehle, and Alexandra Trkola, and John A Robinson
February 1997, Journal of virology,
Markus Seitz, and Peter Rusert, and Kerstin Moehle, and Alexandra Trkola, and John A Robinson
September 1991, Journal of virology,
Markus Seitz, and Peter Rusert, and Kerstin Moehle, and Alexandra Trkola, and John A Robinson
September 1992, Journal of virology,
Markus Seitz, and Peter Rusert, and Kerstin Moehle, and Alexandra Trkola, and John A Robinson
December 1995, Journal of clinical microbiology,
Markus Seitz, and Peter Rusert, and Kerstin Moehle, and Alexandra Trkola, and John A Robinson
June 2001, Journal of virology,
Markus Seitz, and Peter Rusert, and Kerstin Moehle, and Alexandra Trkola, and John A Robinson
July 1993, Journal of virology,
Copied contents to your clipboard!